NIH funds AI project to advance Alzheimer’s research and treatment
The National Institutes of Health has awarded $12.6 million to the Artificial Intelligence for Alzheimer's Disease project to develop AI tools for diagnosing and treating Alzheimer's. The project aims to analyze large-scale datasets to advance the diagnosis and treatment of dementia, and to identify novel drugs that target specific types of dementia.
The National Institutes of Health has renewed support for the Artificial Intelligence for Alzheimer's Disease project. The project, led by Paul M. Thompson, will develop AI tools to uncover the biological causes of Alzheimer's and related dementias. The consortium will analyze large-scale datasets, including whole-genome sequencing and brain imaging. The project aims to improve predictions of disease progression and develop more precise treatment options. The AI tools will be designed to work across global populations, including datasets from African, Indian, Korean, and other ancestry groups. The project builds on the original AI4AD initiative, which developed AI tools to detect Alzheimer's-related patterns in brain scans.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.